Chicago Partners Investment Group’s Jazz Pharmaceuticals JAZZ Stock Holding History

Chicago Partners Investment Group’s Portfolio JAZZ Stock Details JAZZ Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.36M	Buy	5,326 +2,465	+86%	+$540K	0.03%	515
2026 Q1	$579K	Buy	2,861 +867	+43%	+$152K	0.01%	803
2025 Q4	$336K	Buy	+1,994	New	+$306K	0.01%	970
2018 Q4	–	Sell	-215	Closed	-$33K	–	631
2018 Q3	$33K	Hold	215	–	–	﹤0.01%	586
2018 Q2	$37K	Hold	215	–	–	0.01%	546
2018 Q1	$32K	Buy	215 +120	+126%	+$17.6K	0.01%	524
2017 Q4	$13K	Hold	95	–	–	﹤0.01%	701
2017 Q3	$14K	Sell	95 -95	-50%	-$14.4K	﹤0.01%	718
2017 Q2	$25K	Buy	+190	New	+$29.1K	0.01%	486

Other funds holding JAZZ

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return

Vanguard Portfolio Management Malvern, Pennsylvania $2.22T AUM

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

Capital World Investors Los Angeles, California $846B AUM 46.74% 1-Year Est. Return

LSV Asset Management Chicago, Illinois $55.1B AUM 45.38% 1-Year Est. Return

Franklin Resources San Mateo, California $462B AUM 39.16% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Fuller & Thaler Asset Management San Mateo, California $36.7B AUM 74.15% 1-Year Est. Return

Chicago Partners Investment Group's JAZZ Position: Q2 2026 in Review

Chicago Partners Investment Group increased its Jazz Pharmaceuticals (JAZZ) stake by 86% in Q2 2026, buying an estimated $540K and bringing the position to 5,326 shares worth $1.36M. The position accounts for 0.03% of the portfolio, ranked #515.

Chicago Partners Investment Group first reported a position in JAZZ in Q2 2017 and has held it in 9 quarters since. 641 funds tracked by Wall St. Rank hold JAZZ as of Q2 2026.

Chicago Partners Investment Group held 5,326 shares of Jazz Pharmaceuticals worth $1.36M as of Q2 2026.
Chicago Partners Investment Group bought 2,465 Jazz Pharmaceuticals shares in Q2 2026, an estimated $540K.
Jazz Pharmaceuticals made up 0.03% of Chicago Partners Investment Group's portfolio in Q2 2026, its #515 holding.
Chicago Partners Investment Group first reported a position in Jazz Pharmaceuticals in Q2 2017 and has held it in 9 quarters since.
641 funds tracked by Wall St. Rank held Jazz Pharmaceuticals as of Q2 2026.

Based on Chicago Partners Investment Group's 13F filing for Q2 2026, filed 30 Jul 2026.